During the data period, approximately 18.6 million Nexium prescriptions were written. Nexium came close on the heels of hypothyroidism drug levothyroxine (22.6 million prescriptions) and cholesterol-lowering drug Crestor (22.5 million prescriptions).
Nexium netted $6.3 billion in sales, tied with Humira for the second top-selling drug during the data period. Notably, hepatitis C drug Sovaldi generated $4.4 billion in sales.
More Articles on Gastroenterology:
Endoscopy device market to reach $36.9B in 2019
7 gastroenterologists making the news
Young gastroenterologists: the essential skills to thrive in healthcare today
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.